WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

REVIEW ARTICLE ON GARBHINI SHOTH W.S.R TO PIH

Veena Ajay Patil*, Nirupa Ratan Taram and Kiran Shankar Singh

ABSTRACT

The incidence of pre-eclampsia in hospital practice varies widely from 5-15%. The incidence in primigravidae is about 10% and in multigravida 5%. Shotha is one of the eight Garbhopadrava as described by Acharya Harita. Symptoms of Garbhini Shotha described by Acharya Harita like Agnimanya, shirshool, bhrama etc. can be correlated with the symptoms in pre-eclampsia along with pedal oedema. Shotha is the common symptom in pregnancy which appears in last trimester. It’s a part of syndrome PIH, which consists of oedema, hypertension and proteinuria. Preeclampsia, a hypertensive disorder of pregnancy is estimated to complicate 2–8% of pregnancies and remains a principal cause of maternal and foetal morbidity and mortality globally. Preeclampsia may present at any gestation but is more commonly encountered in the third trimester. In India, the incidence of pre-eclampsia is reported to be 8-10% among the pregnant women. The incidence of dependent oedema in normal healthy pregnant women is reported to be 50-80% in 3rd trimester. Early detection and appropriate treatment is the need of the hour to reduce the Shotha and to overcome the complications underlying the Shotha like hypertension, cardiac failure, kidney disorder, anaemia, pre-eclampsia. The treatment in modern medicine for the preeclampsia is mostly empirical and symptomatic. While measures are directed to relieve hypertension, there is no specific therapy for proteinuria which automatically subsides with the control of hypertension. The present study shows the correlation of garbhini shoth with preeclampsia and also pathophysiology, complication, management of preeclampsia.

Keywords: Garbhopadrava, Garbhini Shotha, PIH, Preeclampsia.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More